Compare AQST & VBNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AQST | VBNK |
|---|---|---|
| Founded | 2004 | 1980 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 529.4M | 606.0M |
| IPO Year | 2007 | 2016 |
| Metric | AQST | VBNK |
|---|---|---|
| Price | $4.08 | $21.73 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | $9.00 | ★ $13.00 |
| AVG Volume (30 Days) | ★ 2.2M | 130.9K |
| Earning Date | 05-01-2026 | 06-03-2026 |
| Dividend Yield | N/A | ★ 0.41% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $67,430,000.00 | N/A |
| Revenue This Year | $10.08 | $30.02 |
| Revenue Next Year | $49.60 | $27.30 |
| P/E Ratio | ★ N/A | $25.91 |
| Revenue Growth | ★ 0.77 | N/A |
| 52 Week Low | $2.94 | $10.10 |
| 52 Week High | $7.55 | $24.42 |
| Indicator | AQST | VBNK |
|---|---|---|
| Relative Strength Index (RSI) | 43.48 | 58.93 |
| Support Level | $3.84 | $17.43 |
| Resistance Level | $4.38 | $24.42 |
| Average True Range (ATR) | 0.24 | 1.07 |
| MACD | -0.04 | 0.07 |
| Stochastic Oscillator | 8.47 | 52.50 |
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
VersaBank is a Schedule I Canadian bank that provides mainly commercial lending and banking services to select niche markets in Canada and the United States. Its products and services include credit assets, deposits, and cybersecurity services through its wholly owned subsidiary. The bank operates through four segments: Digital Banking Canada and Digital Banking USA, both using a business-to-business model with proprietary financial technology to serve underserved markets; DRTC, which provides cybersecurity services and banking and financial technology development; and Digital Meteor, which owns proprietary technology supporting next-generation digital assets, including Real Bank Deposit Tokens (RBDTs). The majority of revenue comes from Digital Banking.